Found 145 matching trials
Poly ICLC, Radiation, and Romidepsin for Advanced Cutaneous T Cell Lymphoma
PHASE1This study evaluates the safety and tolerability of the addition of immunos...
Location
NYU Cancer Institute
PSMA and TARP Peptide Vaccine With Poly IC-LC Adjuvant in HLA-A2 (+) Patients With Elevated PSA After Initial Definitive Treatment
NAPilot Immunotherapy Study of Combination Prostate Specific Membrane Antigen...
Location
H. Lee Moffitt Cancer Center & Research Institute
FUSA With Intratumoral PolyICLC in Regionally Advanced Resectable Melanoma
EARLY_PHASE1This study is for adult patients with advanced melanoma who are receiving i...
Location
University of Virginia
Neoepitope-based Personalized Vaccine Approach in Patients With Newly Diagnosed Glioblastoma
PHASE1The early clinical development paradigm for chemotherapeutic agents has sig...
Location
Washington University School of Medicine
Safety Study of Adjuvant Vaccine to Treat Melanoma Patients
PHASE1The incidence of melanoma is increasing with an estimated incidence of 59,9...
Location
New York University Langone Medical Center
A Pilot Study of Glioma Associated Antigen Vaccines in Conjunction with Poly-ICLC in Pediatric Gliomas
PHASE1The overall objective of this pilot study is to collect immunological and s...
Location
Children's Hospital of Pittsburgh of UPMC
Personalized Neoantigen Peptide Vaccines for Solid Tumors
PHASE1This clinical trial is studying the safety and efficacy of a personalized c...
Location
Horizon Cancer Excellence Center, Bumrungrad International Hospital
Phase II Study to Assess the Safety and Immunogenicity of recMAGE-A3+AS15 ASCI With or Without Poly IC:LC
PHASE2The overall purpose of this research study is to find a better way to treat...
Location
H. Lee Moffitt Cancer Center and Research Institute
Clinical Study for the Safety and Therapeutic Efficacy of the AI-QMMM Designed TamavaqTM Personalised Vaccine in Patients With Newly Diagnosed Glioma.
EARLY_PHASE1Gliomas are a heterogeneous group of tumors arising from glial cells in the...
Location
Biogenea Pharmaceuticals Ltd
Application of MRD Combined With Personalized Vaccine in the Treatment of Postoperative Recurrence Prevention of EOC
PHASE2The goal of this clinical trial is as follows:(1) Establish a clinical tech...
Location
Second Affiliated Hospital of Wenzhou Medical University